1. Double-blind evaluation of mepartricin 150.000 U (40 mg) compared with placebo in benign prostatic hypertrophy

2. Mepartricin in BPH. A new dosage approach

3. Mepartricin 150.000 (40 mg) vs mepartricin 50.000 U (13 mg) in the treatment of BIP. Double blind clinical trial

4. Alopecia areata: immunohistochemistry and ultrastructure of infiltrate and identification of adhesion molecule receptors

5. Value of high-dose pure FSH in the treatment of idiopathic male infertility

6. Cyclosporine A inhibits tPA mRNA transcription in A431 cell line
   Torello Lotti Dermatologo Tricologo Roma Firenze

PUBLICATIONS